4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-012571
CHAIRMAN & CEO sold 8,095 shares at an average $27.04 ($218,866)
- CHAIRMAN & CEO acquired 8,095 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanj K CHAIRMAN & CEO | 2025-05-07 | Option exercise 10b5-1 | +1,965 | $1.59 | $3,124 | 98,639 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-07 | Sale 10b5-1 | −1,965 | $27.00 | $53,055 | 96,674 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-08 | Option exercise 10b5-1 | +101 | $1.59 | $161 | 96,775 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-08 | Sale 10b5-1 | −101 | $27.00 | $2,727 | 96,674 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-09 | Option exercise 10b5-1 | +6,029 | $1.59 | $9,586 | 102,703 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-09 | Sale 10b5-1 | −6,029 | $27.05 | $163,084 | 96,674 | D |
| Derivatives | |||||||
| Patel Sanj K CHAIRMAN & CEO | 2025-05-07 | Option exercise · Share Option 10b5-1 | −1,965 | 97,621 | D | ||
| Patel Sanj K CHAIRMAN & CEO | 2025-05-08 | Option exercise · Share Option 10b5-1 | −101 | 97,520 | D | ||
| Patel Sanj K CHAIRMAN & CEO | 2025-05-09 | Option exercise · Share Option 10b5-1 | −6,029 | 91,491 | D | ||
| Open-market sales · 8,095 sh · avg $27.04 · $218,866 | |||||||
Loading xslF345X05/form4-05092025_090511.xml…